NR3C1 and treatment resistant depression: Carvalho et al.5, 6 reported that increased activation of the inflammatory system is concordant with hyperactivity of the hypothalamic–pituitary–adrenal axis and with impaired glucocorticoid receptor (GR) sensitivity in TRD patients.